| primary metabolic process (GO:0044238) | 0.69 | 9 | NBN, BAX, NUP214, TCF3, BCR, TAL1, FLT3, TAL2, PAX5 |
| cellular process (GO:0009987) | 0.26 | 9 | NBN, BAX, NUP214, TCF3, BCR, TAL1, FLT3, TAL2, PAX5 |
| cellular metabolic process (GO:0044237) | 0.69 | 9 | NBN, BAX, NUP214, TCF3, BCR, TAL1, FLT3, TAL2, PAX5 |
| regulation of cellular process (GO:0050794) | 0.5 | 9 | NBN, BAX, NUP214, TCF3, BCR, TAL1, FLT3, TAL2, PAX5 |
| organic substance metabolic process (GO:0071704) | 0.63 | 9 | NBN, BAX, NUP214, TCF3, BCR, TAL1, FLT3, TAL2, PAX5 |
| biological regulation (GO:0065007) | 0.39 | 9 | NBN, BAX, NUP214, TCF3, BCR, TAL1, FLT3, TAL2, PAX5 |
| metabolic process (GO:0008152) | 0.58 | 9 | NBN, BAX, NUP214, TCF3, BCR, TAL1, FLT3, TAL2, PAX5 |
| regulation of biological process (GO:0050789) | 0.45 | 9 | NBN, BAX, NUP214, TCF3, BCR, TAL1, FLT3, TAL2, PAX5 |
| single-organism process (GO:0044699) | 0.48 | 9 | NBN, BAX, NUP214, TCF3, BCR, TAL1, FLT3, TAL2, PAX5 |
| developmental process (GO:0032502) | 1.36 | 8 | NBN, BAX, TCF3, BCR, TAL1, FLT3, TAL2, PAX5 |
| cellular macromolecule metabolic process (GO:0044260) | 0.93 | 8 | NBN, NUP214, TCF3, BCR, TAL1, FLT3, TAL2, PAX5 |
| regulation of metabolic process (GO:0019222) | 1.02 | 8 | NBN, BAX, NUP214, TCF3, TAL1, FLT3, TAL2, PAX5 |
| regulation of macromolecule metabolic process (GO:0060255) | 1.08 | 8 | NBN, BAX, NUP214, TCF3, TAL1, FLT3, TAL2, PAX5 |
| anatomical structure development (GO:0048856) | 1.58 | 8 | NBN, BAX, TCF3, BCR, TAL1, FLT3, TAL2, PAX5 |
| macromolecule metabolic process (GO:0043170) | 0.83 | 8 | NBN, NUP214, TCF3, BCR, TAL1, FLT3, TAL2, PAX5 |
| single-organism cellular process (GO:0044763) | 0.65 | 8 | NBN, BAX, NUP214, TCF3, BCR, TAL1, FLT3, PAX5 |
| regulation of primary metabolic process (GO:0080090) | 1.08 | 7 | NBN, BAX, TCF3, TAL1, FLT3, TAL2, PAX5 |
| regulation of cellular metabolic process (GO:0031323) | 1.07 | 7 | NBN, BAX, TCF3, TAL1, FLT3, TAL2, PAX5 |
| single-organism developmental process (GO:0044767) | 1.49 | 7 | NBN, BAX, TAL1, BCR, FLT3, TAL2, PAX5 |
| nitrogen compound metabolic process (GO:0006807) | 1.13 | 7 | NBN, BAX, NUP214, TCF3, TAL1, TAL2, PAX5 |
| positive regulation of biological process (GO:0048518) | 1.2 | 7 | NBN, BAX, TCF3, BCR, TAL1, FLT3, PAX5 |
| negative regulation of biological process (GO:0048519) | 1.33 | 7 | NBN, BAX, NUP214, TCF3, BCR, TAL1, PAX5 |
| positive regulation of cellular process (GO:0048522) | 1.3 | 7 | NBN, BAX, TCF3, BCR, TAL1, FLT3, PAX5 |
| negative regulation of metabolic process (GO:0009892) | 1.93 | 6 | NBN, BAX, NUP214, TCF3, TAL1, PAX5 |
| positive regulation of metabolic process (GO:0009893) | 1.74 | 6 | NBN, BAX, TCF3, TAL1, FLT3, PAX5 |
| positive regulation of cellular metabolic process (GO:0031325) | 1.81 | 6 | NBN, BAX, TCF3, TAL1, FLT3, PAX5 |
| nucleic acid metabolic process (GO:0090304) | 1.46 | 6 | NBN, NUP214, TCF3, TAL1, TAL2, PAX5 |
| cellular biosynthetic process (GO:0044249) | 1.37 | 6 | NBN, NUP214, TCF3, TAL1, TAL2, PAX5 |
| cellular nitrogen compound metabolic process (GO:0034641) | 1.22 | 6 | NBN, NUP214, TCF3, TAL1, TAL2, PAX5 |
| organic cyclic compound biosynthetic process (GO:1901362) | 1.66 | 6 | NBN, NUP214, TCF3, TAL1, TAL2, PAX5 |
| organic cyclic compound metabolic process (GO:1901360) | 1.26 | 6 | NBN, NUP214, TCF3, TAL1, TAL2, PAX5 |
| nucleobase-containing compound metabolic process (GO:0006139) | 1.35 | 6 | NBN, NUP214, TCF3, TAL1, TAL2, PAX5 |
| negative regulation of macromolecule metabolic process (GO:0010605) | 2.01 | 6 | NBN, BAX, NUP214, TCF3, TAL1, PAX5 |
| positive regulation of macromolecule metabolic process (GO:0010604) | 1.81 | 6 | NBN, BAX, TCF3, TAL1, FLT3, PAX5 |
| regulation of biological quality (GO:0065008) | 1.68 | 6 | NBN, BAX, NUP214, TAL1, FLT3, BCR |
| heterocycle biosynthetic process (GO:0018130) | 1.7 | 6 | NBN, NUP214, TCF3, TAL1, TAL2, PAX5 |
| multicellular organismal process (GO:0032501) | 1.45 | 6 | NBN, BAX, TAL1, PAX5, TAL2, BCR |
| organic substance biosynthetic process (GO:1901576) | 1.34 | 6 | NBN, NUP214, TCF3, TAL1, TAL2, PAX5 |
| regulation of nucleobase-containing compound metabolic process (GO:0019219) | 1.43 | 6 | NBN, BAX, TCF3, TAL1, TAL2, PAX5 |
| cellular aromatic compound metabolic process (GO:0006725) | 1.3 | 6 | NBN, NUP214, TCF3, TAL1, TAL2, PAX5 |
| biosynthetic process (GO:0009058) | 1.32 | 6 | NBN, NUP214, TCF3, TAL1, TAL2, PAX5 |
| macromolecule biosynthetic process (GO:0009059) | 1.61 | 6 | NBN, NUP214, TCF3, TAL1, TAL2, PAX5 |
| regulation of nitrogen compound metabolic process (GO:0051171) | 1.36 | 6 | NBN, BAX, TCF3, TAL1, TAL2, PAX5 |
| nucleobase-containing compound biosynthetic process (GO:0034654) | 1.72 | 6 | NBN, NUP214, TCF3, TAL1, TAL2, PAX5 |
| heterocycle metabolic process (GO:0046483) | 1.31 | 6 | NBN, NUP214, TCF3, TAL1, TAL2, PAX5 |
| cellular nitrogen compound biosynthetic process (GO:0044271) | 1.59 | 6 | NBN, NUP214, TCF3, TAL1, TAL2, PAX5 |
| regulation of cell cycle (GO:0051726) | 2.93 | 6 | NBN, BAX, NUP214, TCF3, TAL1, BCR |
| aromatic compound biosynthetic process (GO:0019438) | 1.7 | 6 | NBN, NUP214, TCF3, TAL1, TAL2, PAX5 |
| negative regulation of cellular process (GO:0048523) | 1.41 | 6 | NBN, BAX, TAL1, TCF3, PAX5, BCR |
| RNA metabolic process (GO:0016070) | 1.59 | 5 | TAL2, TAL1, NUP214, PAX5, TCF3 |
| negative regulation of cellular metabolic process (GO:0031324) | 2.01 | 5 | NBN, BAX, TAL1, PAX5, TCF3 |
| cell differentiation (GO:0030154) | 2.14 | 5 | BAX, FLT3, TAL1, PAX5, TCF3 |
| positive regulation of nucleobase-containing compound metabolic process (GO:0045935) | 2.35 | 5 | NBN, BAX, TAL1, PAX5, TCF3 |
| RNA biosynthetic process (GO:0032774) | 1.84 | 5 | TAL2, TAL1, NUP214, PAX5, TCF3 |
| single-multicellular organism process (GO:0044707) | 1.78 | 5 | NBN, BAX, TAL1, PAX5, TAL2 |
| regulation of cellular macromolecule biosynthetic process (GO:2000112) | 1.46 | 5 | NBN, TAL2, TAL1, PAX5, TCF3 |
| response to stimulus (GO:0050896) | 1.22 | 5 | NBN, BAX, FLT3, BCR, PAX5 |
| positive regulation of nitrogen compound metabolic process (GO:0051173) | 2.29 | 5 | NBN, BAX, TAL1, PAX5, TCF3 |
| regulation of biosynthetic process (GO:0009889) | 1.37 | 5 | NBN, TAL2, TAL1, PAX5, TCF3 |
| regulation of response to stimulus (GO:0048583) | 1.54 | 5 | NBN, BAX, FLT3, BCR, NUP214 |
| regulation of cellular component organization (GO:0051128) | 2.01 | 5 | NBN, BCR, BAX, TAL1, PAX5 |
| immune system process (GO:0002376) | 2.29 | 5 | NBN, BAX, FLT3, PAX5, TCF3 |
| cellular macromolecule biosynthetic process (GO:0034645) | 1.66 | 5 | NBN, TAL2, TAL1, PAX5, TCF3 |
| regulation of macromolecule biosynthetic process (GO:0010556) | 1.43 | 5 | NBN, TAL2, TAL1, PAX5, TCF3 |
| positive regulation of molecular function (GO:0044093) | 2.23 | 5 | NBN, BAX, FLT3, TCF3, BCR |
| cellular developmental process (GO:0048869) | 1.82 | 5 | BAX, FLT3, TAL1, PAX5, TCF3 |
| regulation of gene expression (GO:0010468) | 1.37 | 5 | TAL2, TAL1, NUP214, PAX5, TCF3 |
| regulation of molecular function (GO:0065009) | 1.78 | 5 | NBN, BAX, FLT3, BCR, TCF3 |
| regulation of cellular biosynthetic process (GO:0031326) | 1.38 | 5 | NBN, TAL2, TAL1, PAX5, TCF3 |
| positive regulation of cellular component organization (GO:0051130) | 2.68 | 4 | NBN, BAX, TAL1, BCR |
| negative regulation of nitrogen compound metabolic process (GO:0051172) | 2.47 | 4 | NBN, TAL1, PAX5, TCF3 |
| regulation of organelle organization (GO:0033043) | 2.72 | 4 | NBN, BAX, TAL1, PAX5 |
| B cell activation (GO:0042113) | 4.84 | 4 | NBN, BAX, FLT3, TCF3 |
| leukocyte activation (GO:0045321) | 3.76 | 4 | NBN, BAX, TCF3, FLT3 |
| negative regulation of gene expression (GO:0010629) | 2.48 | 4 | TAL1, PAX5, NUP214, TCF3 |
| signal transduction (GO:0007165) | 1.28 | 4 | NBN, BAX, FLT3, BCR |
| regulation of signaling (GO:0023051) | 1.72 | 4 | NBN, BAX, FLT3, BCR |
| regulation of cell communication (GO:0010646) | 1.73 | 4 | NBN, BAX, FLT3, BCR |
| nucleic acid-templated transcription (GO:0097659) | 1.91 | 4 | TAL2, TAL1, PAX5, TCF3 |
| regulation of mitotic cell cycle (GO:0007346) | 3.71 | 4 | NBN, BAX, TCF3, TAL1 |
| regulation of signal transduction (GO:0009966) | 1.84 | 4 | NBN, BAX, FLT3, BCR |
| regulation of protein metabolic process (GO:0051246) | 1.93 | 4 | NBN, BAX, FLT3, PAX5 |
| cellular component organization (GO:0016043) | 1.24 | 4 | NBN, BAX, BCR, NUP214 |
| animal organ development (GO:0048513) | 2.53 | 4 | BAX, BCR, FLT3, TAL1 |
| regulation of immune system process (GO:0002682) | 2.5 | 4 | BAX, BCR, TCF3, TAL1 |
| cellular component organization or biogenesis (GO:0071840) | 1.22 | 4 | NBN, BAX, BCR, NUP214 |
| regulation of protein modification process (GO:0031399) | 2.32 | 4 | NBN, BAX, FLT3, PAX5 |
| regulation of cell proliferation (GO:0042127) | 2.41 | 4 | BAX, FLT3, TAL1, TCF3 |
| positive regulation of catalytic activity (GO:0043085) | 2.4 | 4 | NBN, BAX, FLT3, BCR |
| negative regulation of nucleobase-containing compound metabolic process (GO:0045934) | 2.55 | 4 | NBN, TAL1, PAX5, TCF3 |
| regulation of developmental process (GO:0050793) | 2.1 | 4 | BAX, TAL1, BCR, TCF3 |
| regulation of catalytic activity (GO:0050790) | 1.97 | 4 | NBN, BAX, FLT3, BCR |
| regulation of nucleic acid-templated transcription (GO:1903506) | 1.55 | 4 | TAL2, TAL1, PAX5, TCF3 |
| cell activation (GO:0001775) | 3.47 | 4 | NBN, BAX, TCF3, FLT3 |
| lymphocyte activation (GO:0046649) | 3.96 | 4 | NBN, BAX, FLT3, TCF3 |
| regulation of multicellular organismal process (GO:0051239) | 1.87 | 4 | BAX, BCR, TAL1, TCF3 |
| regulation of RNA biosynthetic process (GO:2001141) | 1.55 | 4 | TAL2, TAL1, PAX5, TCF3 |
| regulation of intracellular signal transduction (GO:1902531) | 2.31 | 4 | NBN, BAX, FLT3, BCR |
| regulation of cellular protein metabolic process (GO:0032268) | 1.99 | 4 | NBN, BAX, FLT3, PAX5 |
| regulation of RNA metabolic process (GO:0051252) | 1.52 | 4 | TAL2, TAL1, PAX5, TCF3 |
| regulation of transcription, DNA-templated (GO:0006355) | 1.56 | 4 | TAL2, TAL1, PAX5, TCF3 |
| regulation of transcription from RNA polymerase II promoter (GO:0006357) | 2.24 | 4 | TAL2, TAL1, PAX5, TCF3 |
| transcription, DNA-templated (GO:0006351) | 1.91 | 4 | TAL2, TAL1, PAX5, TCF3 |
| regulation of chromosome organization (GO:0033044) | 4.11 | 3 | NBN, TAL1, PAX5 |
| regulation of kinase activity (GO:0043549) | 3.07 | 3 | NBN, BAX, FLT3 |
| regulation of phosphate metabolic process (GO:0019220) | 2.35 | 3 | NBN, BAX, FLT3 |
| negative regulation of biosynthetic process (GO:0009890) | 2.47 | 3 | TAL1, PAX5, TCF3 |
| positive regulation of biosynthetic process (GO:0009891) | 2.29 | 3 | TAL1, PAX5, TCF3 |
| negative regulation of cellular biosynthetic process (GO:0031327) | 2.49 | 3 | TAL1, PAX5, TCF3 |
| regulation of transport (GO:0051049) | 2.24 | 3 | BAX, BCR, NUP214 |
| positive regulation of homeostatic process (GO:0032846) | 4.38 | 3 | NBN, BAX, TAL1 |
| mitotic cell cycle process (GO:1903047) | 3.12 | 3 | NBN, BAX, NUP214 |
| positive regulation of protein metabolic process (GO:0051247) | 2.43 | 3 | NBN, BAX, FLT3 |
| homeostatic process (GO:0042592) | 2.61 | 3 | NBN, BAX, FLT3 |
| positive regulation of developmental process (GO:0051094) | 2.77 | 3 | BAX, TCF3, TAL1 |
| cell cycle process (GO:0022402) | 2.75 | 3 | NBN, BAX, NUP214 |
| regulation of mitotic cell cycle phase transition (GO:1901990) | 4.23 | 3 | NBN, BAX, TCF3 |
| cell surface receptor signaling pathway (GO:0007166) | 2.09 | 3 | BAX, BCR, FLT3 |
| intracellular signal transduction (GO:0035556) | 2.39 | 3 | NBN, BAX, BCR |
| anatomical structure morphogenesis (GO:0009653) | 2.53 | 3 | BAX, BCR, PAX5 |
| multicellular organism development (GO:0007275) | 2.54 | 3 | NBN, TAL1, PAX5 |
| cellular protein metabolic process (GO:0044267) | 1.63 | 3 | BCR, FLT3, NUP214 |
| cellular response to stimulus (GO:0051716) | 1.97 | 3 | NBN, BAX, FLT3 |
| regulation of localization (GO:0032879) | 1.94 | 3 | BAX, BCR, NUP214 |
| positive regulation of transferase activity (GO:0051347) | 3.31 | 3 | NBN, BAX, FLT3 |
| positive regulation of cell cycle (GO:0045787) | 3.94 | 3 | BAX, TCF3, TAL1 |
| negative regulation of transcription from RNA polymerase II promoter (GO:0000122) | 3.12 | 3 | TAL1, PAX5, TCF3 |
| response to lipid (GO:0033993) | 3.11 | 3 | BAX, BCR, FLT3 |
| positive regulation of phosphorus metabolic process (GO:0010562) | 2.78 | 3 | NBN, BAX, FLT3 |
| positive regulation of kinase activity (GO:0033674) | 3.54 | 3 | NBN, BAX, FLT3 |
| regulation of cell cycle process (GO:0010564) | 3.5 | 3 | NBN, BAX, TCF3 |
| negative regulation of cellular macromolecule biosynthetic process (GO:2000113) | 2.6 | 3 | TAL1, PAX5, TCF3 |
| peptidyl-amino acid modification (GO:0018193) | 2.98 | 3 | BCR, FLT3, NUP214 |
| negative regulation of RNA metabolic process (GO:0051253) | 2.66 | 3 | TAL1, PAX5, TCF3 |
| positive regulation of immune system process (GO:0002684) | 2.96 | 3 | BAX, TCF3, TAL1 |
| positive regulation of cellular protein metabolic process (GO:0032270) | 2.49 | 3 | NBN, BAX, FLT3 |
| positive regulation of transcription from RNA polymerase II promoter (GO:0045944) | 2.81 | 3 | TAL1, PAX5, TCF3 |
| positive regulation of nucleic acid-templated transcription (GO:1903508) | 2.56 | 3 | TAL1, PAX5, TCF3 |
| organelle organization (GO:0006996) | 2.02 | 3 | NBN, BAX, BCR |
| positive regulation of phosphate metabolic process (GO:0045937) | 2.78 | 3 | NBN, BAX, FLT3 |
| cell proliferation (GO:0008283) | 3.23 | 3 | NBN, BAX, FLT3 |
| positive regulation of cellular biosynthetic process (GO:0031328) | 2.3 | 3 | TAL1, PAX5, TCF3 |
| positive regulation of multicellular organismal process (GO:0051240) | 2.49 | 3 | BAX, TCF3, TAL1 |
| cellular protein modification process (GO:0006464) | 1.79 | 3 | BCR, FLT3, NUP214 |
| negative regulation of nucleic acid-templated transcription (GO:1903507) | 2.71 | 3 | TAL1, PAX5, TCF3 |
| negative regulation of RNA biosynthetic process (GO:1902679) | 2.7 | 3 | TAL1, PAX5, TCF3 |
| reproductive process (GO:0022414) | 2.55 | 3 | NBN, BAX, PAX5 |
| macromolecule modification (GO:0043412) | 1.73 | 3 | BCR, FLT3, NUP214 |
| protein modification process (GO:0036211) | 1.79 | 3 | BCR, FLT3, NUP214 |
| negative regulation of transcription, DNA-templated (GO:0045892) | 2.75 | 3 | TAL1, PAX5, TCF3 |
| positive regulation of transcription, DNA-templated (GO:0045893) | 2.56 | 3 | TAL1, PAX5, TCF3 |
| response to chemical (GO:0042221) | 1.98 | 3 | BAX, FLT3, BCR |
| regulation of homeostatic process (GO:0032844) | 3.65 | 3 | NBN, BAX, TAL1 |
| response to organic substance (GO:0010033) | 2.2 | 3 | BAX, BCR, FLT3 |
| leukocyte differentiation (GO:0002521) | 4.13 | 3 | FLT3, TAL1, TCF3 |
| regulation of phosphorylation (GO:0042325) | 2.5 | 3 | NBN, BAX, FLT3 |
| regulation of phosphorus metabolic process (GO:0051174) | 2.35 | 3 | NBN, BAX, FLT3 |
| positive regulation of phosphorylation (GO:0042327) | 2.9 | 3 | NBN, BAX, FLT3 |
| single organism reproductive process (GO:0044702) | 2.73 | 3 | NBN, BAX, PAX5 |
| nervous system development (GO:0007399) | 3.53 | 3 | BAX, TCF3, PAX5 |
| regulation of cell cycle phase transition (GO:1901987) | 4.15 | 3 | NBN, BAX, TCF3 |
| protein metabolic process (GO:0019538) | 1.45 | 3 | BCR, FLT3, NUP214 |
| regulation of response to stress (GO:0080134) | 2.53 | 3 | BAX, BCR, NUP214 |
| positive regulation of protein modification process (GO:0031401) | 2.7 | 3 | NBN, BAX, FLT3 |
| positive regulation of organelle organization (GO:0010638) | 3.38 | 3 | NBN, BAX, TAL1 |
| positive regulation of RNA metabolic process (GO:0051254) | 2.51 | 3 | TAL1, PAX5, TCF3 |
| regulation of transferase activity (GO:0051338) | 2.88 | 3 | NBN, BAX, FLT3 |
| positive regulation of protein phosphorylation (GO:0001934) | 2.95 | 3 | NBN, BAX, FLT3 |
| positive regulation of RNA biosynthetic process (GO:1902680) | 2.54 | 3 | TAL1, PAX5, TCF3 |
| positive regulation of macromolecule biosynthetic process (GO:0010557) | 2.39 | 3 | TAL1, PAX5, TCF3 |
| positive regulation of gene expression (GO:0010628) | 2.35 | 3 | TAL1, PAX5, TCF3 |
| regulation of multicellular organismal development (GO:2000026) | 2.31 | 3 | BAX, TCF3, TAL1 |
| system development (GO:0048731) | 2.92 | 3 | BAX, TCF3, PAX5 |
| regulation of protein phosphorylation (GO:0001932) | 2.57 | 3 | NBN, BAX, FLT3 |
| negative regulation of macromolecule biosynthetic process (GO:0010558) | 2.53 | 3 | TAL1, PAX5, TCF3 |
| developmental growth (GO:0048589) | 4.05 | 2 | NBN, TAL2 |
| anatomical structure homeostasis (GO:0060249) | 4.25 | 2 | NBN, BAX |
| negative regulation of response to stimulus (GO:0048585) | 2.52 | 2 | BAX, BCR |
| positive regulation of response to stimulus (GO:0048584) | 2.18 | 2 | BAX, FLT3 |
| cell development (GO:0048468) | 3.28 | 2 | BAX, TAL1 |
| behavior (GO:0007610) | 3.47 | 2 | TAL1, PAX5 |
| membrane organization (GO:0061024) | 3.04 | 2 | BAX, NUP214 |
| enzyme linked receptor protein signaling pathway (GO:0007167) | 3.24 | 2 | BCR, FLT3 |
| transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169) | 3.54 | 2 | BCR, FLT3 |
| single-organism metabolic process (GO:0044710) | 1.63 | 2 | NBN, BAX |
| negative regulation of cell cycle (GO:0045786) | 3.67 | 2 | NBN, BAX |
| positive regulation of signal transduction (GO:0009967) | 2.5 | 2 | BAX, FLT3 |
| peptidyl-tyrosine modification (GO:0018212) | 4.47 | 2 | BCR, FLT3 |
| regulation of programmed cell death (GO:0043067) | 2.49 | 2 | BAX, FLT3 |
| interspecies interaction between organisms (GO:0044419) | 3.08 | 2 | BAX, NUP214 |
| multi-organism process (GO:0051704) | 2.65 | 2 | BAX, NUP214 |
| positive regulation of DNA metabolic process (GO:0051054) | 4.49 | 2 | NBN, BAX |
| regulation of DNA metabolic process (GO:0051052) | 3.87 | 2 | NBN, BAX |
| positive regulation of transport (GO:0051050) | 2.9 | 2 | BAX, BCR |
| response to corticosteroid (GO:0031960) | 4.56 | 2 | BAX, FLT3 |
| regulation of protein kinase activity (GO:0045859) | 3.15 | 2 | BAX, FLT3 |
| establishment of protein localization (GO:0045184) | 2.53 | 2 | BAX, NUP214 |
| spermatogenesis (GO:0007283) | 3.7 | 2 | BAX, PAX5 |
| system process (GO:0003008) | 2.3 | 2 | NBN, BCR |
| post-embryonic development (GO:0009791) | 5.35 | 2 | BAX, TAL2 |
| homeostasis of number of cells (GO:0048872) | 4.98 | 2 | BAX, FLT3 |
| response to organonitrogen compound (GO:0010243) | 3.2 | 2 | BAX, FLT3 |
| negative regulation of organelle organization (GO:0010639) | 4.07 | 2 | NBN, PAX5 |
| cellular response to stress (GO:0033554) | 2.51 | 2 | NBN, BAX |
| somatic diversification of immunoglobulins (GO:0016445) | 6.26 | 2 | NBN, TCF3 |
| somatic cell DNA recombination (GO:0016444) | 6.23 | 2 | NBN, TCF3 |
| somatic recombination of immunoglobulin gene segments (GO:0016447) | 6.68 | 2 | NBN, TCF3 |
| regulation of anatomical structure morphogenesis (GO:0022603) | 2.79 | 2 | BAX, BCR |
| mononuclear cell proliferation (GO:0032943) | 5.32 | 2 | BAX, FLT3 |
| lymphocyte proliferation (GO:0046651) | 5.35 | 2 | BAX, FLT3 |
| signal transduction by p53 class mediator (GO:0072331) | 4.88 | 2 | NBN, BAX |
| positive regulation of hydrolase activity (GO:0051345) | 2.91 | 2 | BAX, BCR |
| DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 5.3 | 2 | NBN, BAX |
| somatic diversification of immune receptors (GO:0002200) | 5.92 | 2 | NBN, TCF3 |
| organ morphogenesis (GO:0009887) | 3.55 | 2 | BAX, PAX5 |
| transport (GO:0006810) | 1.51 | 2 | BAX, NUP214 |
| cellular response to organic substance (GO:0071310) | 2.78 | 2 | BAX, FLT3 |
| leukocyte homeostasis (GO:0001776) | 5.72 | 2 | BAX, FLT3 |
| response to stress (GO:0006950) | 1.8 | 2 | NBN, BAX |
| single-organism membrane organization (GO:0044802) | 3.19 | 2 | BAX, NUP214 |
| positive regulation of intracellular signal transduction (GO:1902533) | 2.95 | 2 | BAX, FLT3 |
| regulation of protein complex assembly (GO:0043254) | 3.83 | 2 | BAX, TAL1 |
| establishment of localization (GO:0051234) | 1.48 | 2 | BAX, NUP214 |
| negative regulation of cell cycle phase transition (GO:1901988) | 4.74 | 2 | NBN, BAX |
| regulation of hydrolase activity (GO:0051336) | 2.53 | 2 | BAX, BCR |
| cell fate commitment (GO:0045165) | 4.72 | 2 | TCF3, TAL1 |
| brain development (GO:0007420) | 4.24 | 2 | BAX, BCR |
| negative regulation of protein modification process (GO:0031400) | 3.4 | 2 | BAX, PAX5 |
| regulation of cellular response to stress (GO:0080135) | 3.4 | 2 | BAX, NUP214 |
| regulation of leukocyte activation (GO:0002694) | 3.6 | 2 | TCF3, BCR |
| positive regulation of chromosome organization (GO:2001252) | 4.76 | 2 | NBN, TAL1 |
| negative regulation of chromosome organization (GO:2001251) | 5.17 | 2 | NBN, PAX5 |
| phosphorylation (GO:0016310) | 2.63 | 2 | BCR, FLT3 |
| negative regulation of cellular component organization (GO:0051129) | 3.35 | 2 | NBN, PAX5 |
| positive regulation of signaling (GO:0023056) | 2.41 | 2 | BAX, FLT3 |
| negative regulation of mitotic cell cycle phase transition (GO:1901991) | 4.82 | 2 | NBN, BAX |
| cellular response to chemical stimulus (GO:0070887) | 2.57 | 2 | BAX, FLT3 |
| positive regulation of cell communication (GO:0010647) | 2.41 | 2 | BAX, FLT3 |
| protein autophosphorylation (GO:0046777) | 4.46 | 2 | BCR, FLT3 |
| response to organic cyclic compound (GO:0014070) | 3.07 | 2 | BAX, FLT3 |
| response to endogenous stimulus (GO:0009719) | 2.79 | 2 | BAX, FLT3 |
| negative regulation of protein metabolic process (GO:0051248) | 2.82 | 2 | BAX, PAX5 |
| neuromuscular process controlling balance (GO:0050885) | 5.88 | 2 | NBN, BCR |
| signal transduction in response to DNA damage (GO:0042770) | 5.15 | 2 | NBN, BAX |
| positive regulation of cell proliferation (GO:0008284) | 3.01 | 2 | TCF3, FLT3 |
| DNA recombination (GO:0006310) | 4.39 | 2 | NBN, TCF3 |
| multicellular organismal reproductive process (GO:0048609) | 3.35 | 2 | BAX, PAX5 |
| somatic diversification of immune receptors via germline recombination within a single locus (GO:0002562) | 6.23 | 2 | NBN, TCF3 |
| establishment of protein localization to organelle (GO:0072594) | 3.92 | 2 | BAX, NUP214 |
| positive regulation of protein complex assembly (GO:0031334) | 4.44 | 2 | BAX, TAL1 |
| cellular response to DNA damage stimulus (GO:0006974) | 3.17 | 2 | NBN, BAX |
| regulation of cell differentiation (GO:0045595) | 2.42 | 2 | TCF3, TAL1 |
| male gamete generation (GO:0048232) | 3.7 | 2 | BAX, PAX5 |
| negative regulation of cellular protein metabolic process (GO:0032269) | 2.88 | 2 | BAX, PAX5 |
| regulation of immune response (GO:0050776) | 2.98 | 2 | BAX, BCR |
| aging (GO:0007568) | 4.16 | 2 | BAX, PAX5 |
| regulation of G1/S transition of mitotic cell cycle (GO:2000045) | 4.81 | 2 | BAX, TCF3 |
| response to hormone (GO:0009725) | 3.33 | 2 | BAX, FLT3 |
| lymphocyte differentiation (GO:0030098) | 4.49 | 2 | TCF3, FLT3 |
| hemopoiesis (GO:0030097) | 5.07 | 2 | FLT3, TAL1 |
| positive regulation of protein kinase activity (GO:0045860) | 3.61 | 2 | BAX, FLT3 |
| response to nitrogen compound (GO:1901698) | 3.12 | 2 | BAX, FLT3 |
| response to steroid hormone (GO:0048545) | 4.24 | 2 | BAX, FLT3 |
| regulation of chromatin organization (GO:1902275) | 4.69 | 2 | TAL1, PAX5 |
| response to glucocorticoid (GO:0051384) | 4.63 | 2 | BAX, FLT3 |
| regulation of cell activation (GO:0050865) | 3.53 | 2 | TCF3, BCR |
| apoptotic signaling pathway (GO:0097190) | 4.12 | 2 | NBN, BAX |
| peptidyl-tyrosine phosphorylation (GO:0018108) | 4.48 | 2 | BCR, FLT3 |
| intrinsic apoptotic signaling pathway (GO:0097193) | 4.69 | 2 | NBN, BAX |
| negative regulation of cell cycle process (GO:0010948) | 4.37 | 2 | NBN, BAX |
| neuromuscular process (GO:0050905) | 5.27 | 2 | NBN, BCR |
| regulation of cell death (GO:0010941) | 2.43 | 2 | BAX, FLT3 |
| cerebral cortex development (GO:0021987) | 5.57 | 2 | BAX, PAX5 |
| gamete generation (GO:0007276) | 3.61 | 2 | BAX, PAX5 |
| growth (GO:0040007) | 3.8 | 2 | NBN, TAL2 |
| regulation of apoptotic process (GO:0042981) | 2.5 | 2 | BAX, FLT3 |
| single-organism organelle organization (GO:1902589) | 2.68 | 2 | BAX, BCR |
| leukocyte proliferation (GO:0070661) | 5.25 | 2 | BAX, FLT3 |
| hematopoietic progenitor cell differentiation (GO:0002244) | 5.23 | 2 | FLT3, TAL1 |
| neurological system process (GO:0050877) | 2.64 | 2 | NBN, BCR |
| hematopoietic or lymphoid organ development (GO:0048534) | 4.49 | 2 | FLT3, TAL1 |
| embryonic morphogenesis (GO:0048598) | 3.72 | 2 | BCR, PAX5 |
| negative regulation of mitotic cell cycle (GO:0045930) | 4.45 | 2 | NBN, BAX |
| protein phosphorylation (GO:0006468) | 2.89 | 2 | BCR, FLT3 |
| regulation of tissue remodeling (GO:0034103) | 5.55 | 2 | BAX, BCR |
| B cell differentiation (GO:0030183) | 5.24 | 2 | TCF3, FLT3 |
| multi-organism cellular process (GO:0044764) | 3.14 | 2 | BAX, NUP214 |
| establishment of localization in cell (GO:0051649) | 2.47 | 2 | BAX, NUP214 |
| localization (GO:0051179) | 1.4 | 2 | BAX, NUP214 |
| single-organism localization (GO:1902578) | 2.09 | 2 | BAX, NUP214 |
| response to oxygen-containing compound (GO:1901700) | 2.57 | 2 | BAX, BCR |
| positive regulation of cell differentiation (GO:0045597) | 3.01 | 2 | TCF3, TAL1 |
| regulation of cell cycle G1/S phase transition (GO:1902806) | 4.74 | 2 | BAX, TCF3 |
| regulation of cellular component biogenesis (GO:0044087) | 3.08 | 2 | BAX, TAL1 |
| phosphate-containing compound metabolic process (GO:0006796) | 2.16 | 2 | BCR, FLT3 |
| viral process (GO:0016032) | 3.15 | 2 | BAX, NUP214 |
| phosphorus metabolic process (GO:0006793) | 2.15 | 2 | BCR, FLT3 |
| DNA metabolic process (GO:0006259) | 3.09 | 2 | NBN, TCF3 |
| symbiosis, encompassing mutualism through parasitism (GO:0044403) | 3.15 | 2 | BAX, NUP214 |
| positive regulation of cellular component biogenesis (GO:0044089) | 3.71 | 2 | BAX, TAL1 |